Neural Network Enhanced Structure Determination of Osteoporosis, Immune System, and Radiation Repair Proteins, Phase II

We propose a dual objective innovation that has valuable NASA applicability and tremendous commercial potential. The first innovation is the structure determination of osteoporosis, immune system diseases, and radiation damage repair proteins utilizing proprietary neural network based algorithms. The long-term results from this innovation could provide effective medical countermeasures for bone loss, immune system compromise and harmful radiation effects seen in astronauts upon long-duration space missions. The second innovation is a commercial grade multipurpose neural network based informatics system configurable for automated, real-time sensory data input and automatic correlation identification applicable to autonomous astronaut health monitoring and environmental correlation. This innovation also has significant commercial applications in the health care industries as a hospital wide health monitoring and environmental correlation system.

This is a mature technology (TRL 7+) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.